Ratings
0
Nobody has rated this yet. Be the first!
Works
9
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity
Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity
Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon
Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector
Common structure of rare replication-deficient E1-positive particles in adenoviral vector batches
Quantification of residual host cell DNA in adenoviral vectors produced on PER.C6 cells
Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys
Highly Conserved Protective Epitopes on Influenza B Viruses
First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001)
Lists
0
.jpg/500px-Jaap_Goudsmit_(2017).jpg)
